AACR’s Project GENIE hits another phenomenal milestone: 9th public data set now released
Launched by the American Association for Cancer [...]
Driving nano-based approaches closer to the clinic: Vall d’Hebron leads pilot study to assess the efficacy of nanoparticles against pancreatic cancer
The Horizon 2020 funded NoCANTher European Consortium*, [...]
VHIO-led study unveils novel mechanism of resistance to T-cell bispecific antibodies and CAR-T targeting HER2 breast cancer
Redirection of lymphocytes, via T-cell bispecific antibodies [...]
Proof-of-concept study points to the placenta as a protective barrier against COVID-19 during pregnancy
Findings from a comprehensive clinical, morphological, and [...]
Expert panel discussion: latest treatment regimens, novel therapies and advances against NSCLC
Published this week as part of ecancer’s [...]
2020: a record-breaking year for VHIO’s Research Unit for Molecular Cancer Therapy (UITM) – “la Caixa” Foundation
Throughout 2020 and during the COVID-19 pandemic [...]
A new radiomic model based on artificial intelligence will help to predict the response to immunotherapy in cancer patients
Researchers from the VHIO, promoted by the [...]
World Cancer Day 2021: saluting the strength of the cancer community through the COVID-19 pandemic
Thursday, February 04 2021, not only celebrates [...]
The passing of a true giant and trailblazer in oncology: Prof. Gordon McVie 1945-2021
Officially announced yesterday by ecancer, Prof. Gordon [...]
Not to be missed: ESMO’s virtual and expert Live Roundtable on COVID-19 vaccination in cancer patients, this Friday 22 January
Delivering on the European Society for Medical [...]